Medifast, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses), averaging +58.2% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.67 | $-0.28 | +58.2% | Beat | Q2 FY26 call |
| Q1 FY26 | not reported | $-0.19 | not reported | not reported |
Back to MED overview · MED holders · MED KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.